Track Conduit Pharmaceuticals's intangible assets ($380M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), CDT shows a intangible assets of $380M. That compares with $420M in the prior-year period — down 8.3% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, CDT's intangible assets is now $380M (was $420M) — a 8.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Conduit Pharmaceuticals is outperforming or lagging.
Tracking CDT's intangible assets over time shows whether Conduit Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $380M That compares with $420M in the prior-year period — down 8.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this intangible assets page, Stockcircle has Conduit Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $380M) with ownership activity and broader fundamentals.